Formulation and lyophilization
Many oligonucleotide products are formulated for parenteral administration and then lyophilized. We optimize your formulation by evaluating your drug’s solubility and stability and checking for compatibility with excipients. We have all the necessary capabilities to develop, optimize, and validate a lyophilization cycle for your product. Our studies are conducted under protocol to generate data that will support your regulatory filings.